Lung toxicity associated with cyclophosphamide use. Two distinct patterns.
about
Immunomodulatory agents for idiopathic pulmonary fibrosisDerivation and validation of automated electronic search strategies to identify pertinent risk factors for postoperative acute lung injuryPharmacological Threat to Lungs: A Case Series and Literature Review.Scleroderma lung diseaseColchicine versus prednisone in the treatment of idiopathic pulmonary fibrosis. A randomized prospective study. Members of the Lung Study Group.Idiopathic pulmonary fibrosis: current and future treatment options.Unusual progression and subsequent improvement in cystic lung disease in a child with radiation-induced lung injuryPulmonary Function After Treatment for Embryonal Brain Tumors on SJMB03 That Included Craniospinal Irradiation.Pulmonary function testing prior to hematopoietic stem cell transplantation.Pneumonitis and pulmonary fibrosis in a patient receiving adjuvant docetaxel and cyclophosphamide for stage 3 breast cancer: a case report and literature review.Ground-glass opacity in lung metastasis from breast cancer: a case report.Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelinesPneumocystis pneumonia in a non-HIV patient on chronic corticosteroid therapy: a question of prophylaxisPost-transplant bendamustine reduces GvHD while preserving GvL in experimental haploidentical bone marrow transplantation.Cyclophosphamide enhances human tumor growth in nude rat xenografted tumor modelsTherapies for interstitial lung disease: past, present and future.Pulmonary outcomes in survivors of childhood cancer: a systematic review.Successful rituximab therapy in a lupus patient with diffuse alveolar haemorrhage.Chlorambucil-induced acute interstitial pneumonitis.Acute respiratory failure during first cyclophosphamide infusion in a patient with systemic lupus erythematosus.Pneumonitis and pulmonary fibrosis associated with breast cancer treatments.Paclitaxel-induced pneumonitis in patients with breast cancer: case series and review of the literature.Role of (18)F-FDG PET-CT in Monitoring the Cyclophosphamide Induced Pulmonary Toxicity in Patients with Breast Cancer - 2 Case Reports.Characteristics of Traditional Chinese Medicine Use in Pediatric Cancer Patients: A Nationwide, Retrospective, Taiwanese-Registry, Population-Based Study.Late-onset noninfectious interstitial lung disease following autologous haematopoietic stem cell transplantation in paediatric patients.Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphoma.Pulmonary toxicity syndrome following CDEP (cyclophosphamide, dexamethasone, etoposide, cisplatin) chemotherapy.Pulmonary Function after Treatment for Childhood Cancer. A Report from the St. Jude Lifetime Cohort Study (SJLIFE).Cuscuta chinensis Ameliorates Immunosuppression and Urotoxic Effect of Cyclophosphamide by Regulating Cytokines - GM-CSF and TNF-Alpha.Usual interstitial pneumonia following resolution of cavitated pulmonary masses in a patient with ANCA-associated vasculitis.Is pirfenidone ready for use in non-idiopathic pulmonary fibrosis interstitial lung diseases?The dose of cyclophosphamide for treating paraquat-induced rat lung injury.Amiodarone and cyclophosphamide: potential for enhanced lung toxicity.Thymoquinone attenuates cyclophosphamide-induced pulmonary injury in rats.Asbestos exposure and benign asbestos diseases in 772 formerly exposed workers: dose-response relationships.A rare case of interstitial pneumonitis after tandem high-dose melphalan conditioning and autologous stem cell transplantation in multiple myeloma.[18F]-fluorodeoxyglucose positron emission tomography combined with computed tomography detection of asymptomatic late pulmonary toxicity in patients with non-Hodgkin lymphoma treated with rituximab-containing chemotherapy.Modulation of cyclophosphamide-induced early lung injury by allicin.Obstructive and restrictive pulmonary dysfunction in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation.Activity of lung neutrophils and matrix metalloproteinases in cyclophosphamide-treated mice with experimental sepsis.
P2860
Q24248714-4F97A4C1-8C1E-4B0D-948E-E620223AB0F6Q28388169-8A3BCFD1-DB3E-4494-88ED-94FAEBB24997Q33787981-1D8345A7-C580-43BB-8E13-AB905C7DDE37Q33919119-651CD727-0A5D-462C-A01B-2A5B8D48A463Q34748983-EC663720-7E61-40DA-9AE7-B885C1215949Q35627863-10E8EB27-4405-41D5-9E2C-CD306006CD7BQ35674952-52A0C3D0-BCE5-4DF1-9021-F0AA14565748Q35747427-0BC29ECC-314D-4C6C-8E10-DD150D02B382Q36011668-B1C511CA-4E8C-4132-B058-C65F9D67EA5DQ36499095-E27B2853-39BC-4468-9903-81C6C0863424Q36585596-C40B25D2-547D-4B09-9157-C401BF6273D8Q36724093-5A4FDC93-F4FC-46EE-BFDE-11C53D6A8FE8Q36745959-1E45C9CB-D428-45E9-9FEB-6754CDA0E494Q37029856-DE276EDB-0549-4231-9948-D3F7FD9051F7Q37073278-494C763F-333B-42FA-9BF9-9E32159ED4C6Q37362642-7926B396-7811-497C-BC52-886BBFF3D21AQ37523788-6720E835-B0C3-4D38-B5E7-B9296A26353FQ37845011-AB52DB27-DED8-4502-8832-691D73CA5681Q38202645-7EE87914-E6E8-46E8-9922-32B4CA1C904DQ38211917-A112C549-D5DB-4E76-B464-087CCC8CD207Q38220276-68BA2DFF-49BC-45B1-A38B-57DF0181370AQ38482637-1B0378D4-75BB-4A25-A648-194B56568D54Q39474553-7C7432A2-9EF9-4BE8-9EC1-DF2543BFCB84Q39609109-708EA57D-02E0-46EE-AE7F-3291CEAF5963Q39855262-9171F9F5-7064-41F4-A872-EEC59CCD95A5Q40409474-1FD791D7-8D85-403E-915D-03050436263AQ40596053-BE843E73-7B4B-4D47-BD1E-7D684F4F7A36Q40661649-07C04816-CD1E-4085-9D3A-881D5013D185Q41031610-D0094C97-3775-4208-B925-A5AF3C5F97C7Q41588379-2835AA43-7A4C-4F35-A1BF-32F47DEE9911Q42961772-052CCA93-5333-4306-8CFF-23AC84DE3D76Q43090747-810BBA0A-A368-457A-9C9D-840BBCE14D88Q43662960-9E6820B4-7172-4D2A-9B42-3A96BF2FEFB5Q44146637-3E9CE2B1-0BA5-451C-A995-CB0B41057AC6Q44661776-97D367CD-3AE6-48A3-9BDA-1F5C190173AEQ44971633-C28488AF-1104-4D95-AE89-2AEE23E2B361Q45185229-0E48A725-40A8-4BC9-B0BE-2A9F77575919Q46170810-8106AF09-3DB5-4CB3-82B3-5160303BB199Q47207681-3347AC44-0217-41DC-A9A5-ED2FA4FA331AQ47955384-5796B61A-4FF3-4E03-AF75-FF8F2703DEF7
P2860
Lung toxicity associated with cyclophosphamide use. Two distinct patterns.
description
1996 nî lūn-bûn
@nan
1996 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Lung toxicity associated with cyclophosphamide use. Two distinct patterns.
@ast
Lung toxicity associated with cyclophosphamide use. Two distinct patterns.
@en
Lung toxicity associated with cyclophosphamide use. Two distinct patterns.
@nl
type
label
Lung toxicity associated with cyclophosphamide use. Two distinct patterns.
@ast
Lung toxicity associated with cyclophosphamide use. Two distinct patterns.
@en
Lung toxicity associated with cyclophosphamide use. Two distinct patterns.
@nl
prefLabel
Lung toxicity associated with cyclophosphamide use. Two distinct patterns.
@ast
Lung toxicity associated with cyclophosphamide use. Two distinct patterns.
@en
Lung toxicity associated with cyclophosphamide use. Two distinct patterns.
@nl
P2093
P1476
Lung toxicity associated with cyclophosphamide use. Two distinct patterns.
@en
P2093
P304
P356
10.1164/AJRCCM.154.6.8970380
P407
P433
P577
1996-12-01T00:00:00Z